Guangdong Hybribio Biotech (300639.SZ) plans to spend 50 million to 100 million yuan to repurchase shares, with the repurchase price not exceeding 9 yuan per share.
Capstone Biology (300639.SZ) announced that the company plans to use its own funds and bank special repurchase loan funds in order to concentrate...
Guangdong Hybribio Biotech (300639.SZ) announced that the company plans to use own funds and bank special repurchase loan funds to repurchase some of its shares through centralized competitive trading. The total amount of funds will not be less than RMB 50 million (inclusive) and not exceed RMB 100 million (inclusive). The repurchase price of the shares shall not exceed RMB 9.00 per share (inclusive). The implementation period of the share repurchase shall not exceed 3 months from the date of approval by the board of directors.
Related Articles

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


